{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T15:37:24Z","timestamp":1778254644527,"version":"3.51.4"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2016,8,24]],"date-time":"2016-08-24T00:00:00Z","timestamp":1471996800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Hum Genet"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1038\/ejhg.2016.97","type":"journal-article","created":{"date-parts":[[2016,8,24]],"date-time":"2016-08-24T10:22:31Z","timestamp":1472034151000},"page":"1707-1714","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Chromosomal abnormalities in hepatic cysts point to novel polycystic liver disease genes"],"prefix":"10.1038","volume":"24","author":[{"given":"Edgar S","family":"Wills","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wybrich R","family":"Cnossen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joris A","family":"Veltman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rob","family":"Woestenenk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marloes","family":"Steehouwer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jody","family":"Salomon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ren\u00e9 H M","family":"te Morsche","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meritxell","family":"Huch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jayne Y","family":"Hehir-Kwa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martijn J","family":"Banning","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rolph","family":"Pfundt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronald","family":"Roepman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Hoischen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joost P H","family":"Drenth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,8,24]]},"reference":[{"key":"BFejhg201697_CR1","doi-asserted-by":"publisher","first-page":"64","DOI":"10.2215\/CJN.00080605","volume":"1","author":"KT Bae","year":"2006","unstructured":"Bae KT, Zhu F, Chapman AB et al: Magnetic resonance imaging evaluation of hepatic cysts in early autosomal-dominant polycystic kidney disease: the Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease cohort. Clin J Am Soc Nephrol 2006; 1: 64\u201369.","journal-title":"Clin J Am Soc Nephrol"},{"key":"BFejhg201697_CR2","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1053\/j.ackd.2010.01.003","volume":"17","author":"Y Pirson","year":"2010","unstructured":"Pirson Y : Extrarenal manifestations of autosomal dominant polycystic kidney disease. Adv Chronic Kidney Dis 2010; 17: 173\u2013180.","journal-title":"Adv Chronic Kidney Dis"},{"key":"BFejhg201697_CR3","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1002\/humu.9441","volume":"27","author":"E Waanders","year":"2006","unstructured":"Waanders E, te Morsche RH, de Man RA, Jansen JB, Drenth JP : Extensive variantal analysis of PRKCSH and SEC63 broadens the spectrum of polycystic liver disease. Hum Mutat 2006; 27: 830.","journal-title":"Hum Mutat"},{"key":"BFejhg201697_CR4","doi-asserted-by":"publisher","first-page":"5343","DOI":"10.1073\/pnas.1309438111","volume":"111","author":"WR Cnossen","year":"2014","unstructured":"Cnossen WR, te Morsche RH, Hoischen A et al: Whole-exome sequencing reveals LRP5 variants and canonical Wnt signaling associated with hepatic cystogenesis. Proc Natl Acad Sci USA 2014; 111: 5343\u20135348.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFejhg201697_CR5","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1146\/annurev.med.60.101707.125712","volume":"60","author":"PC Harris","year":"2009","unstructured":"Harris PC, Torres VE : Polycystic kidney disease. Annu Rev Med 2009; 60: 321\u2013337.","journal-title":"Annu Rev Med"},{"key":"BFejhg201697_CR6","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.molmed.2014.01.003","volume":"20","author":"ES Wills","year":"2014","unstructured":"Wills ES, Roepman R, Drenth JP : Polycystic liver disease: ductal plate malformation and the primary cilium. Trends Mol Med 2014; 20: 261\u2013270.","journal-title":"Trends Mol Med"},{"key":"BFejhg201697_CR7","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.molmed.2014.01.004","volume":"20","author":"SV Fedeles","year":"2014","unstructured":"Fedeles SV, Gallagher AR, Somlo S : Polycystin-1: a master regulator of intersecting cystic pathways. Trends Mol Med 2014; 20: 251\u2013260.","journal-title":"Trends Mol Med"},{"key":"BFejhg201697_CR8","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1038\/ng.860","volume":"43","author":"SV Fedeles","year":"2011","unstructured":"Fedeles SV, Tian X, Gallagher AR et al: A genetic interaction network of five genes for human polycystic kidney and liver diseases defines polycystin-1 as the central determinant of cyst formation. Nat Genet 2011; 43: 639\u2013647.","journal-title":"Nat Genet"},{"key":"BFejhg201697_CR9","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1038\/ng.2715","volume":"45","author":"M Ma","year":"2013","unstructured":"Ma M, Tian X, Igarashi P, Pazour GJ, Somlo S : Loss of cilia suppresses cyst growth in genetic models of autosomal dominant polycystic kidney disease. Nat Genet 2013; 45: 1004\u20131012.","journal-title":"Nat Genet"},{"key":"BFejhg201697_CR10","doi-asserted-by":"publisher","first-page":"e50324","DOI":"10.1371\/journal.pone.0050324","volume":"7","author":"MJ Janssen","year":"2012","unstructured":"Janssen MJ, Salomon J, Te Morsche RH, Drenth JP : Loss of heterozygosity is present in SEC63 germline carriers with polycystic liver disease. PLoS One 2012; 7: e50324.","journal-title":"PLoS One"},{"key":"BFejhg201697_CR11","doi-asserted-by":"publisher","first-page":"e2052","DOI":"10.1053\/j.gastro.2011.08.004","volume":"141","author":"MJ Janssen","year":"2011","unstructured":"Janssen MJ, Waanders E, Te Morsche RH et al: Secondary, somatic variants might promote cyst formation in patients with autosomal dominant polycystic liver disease. Gastroenterology 2011; 141: e2052.","journal-title":"Gastroenterology"},{"key":"BFejhg201697_CR12","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/S1471-4914(01)01953-0","volume":"7","author":"Y Pei","year":"2001","unstructured":"Pei Y : A \"two-hit\" model of cystogenesis in autosomal dominant polycystic kidney disease? Trends Mol Med 2001; 7: 151\u2013156.","journal-title":"Trends Mol Med"},{"key":"BFejhg201697_CR13","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1681\/ASN.V1071524","volume":"10","author":"Y Pei","year":"1999","unstructured":"Pei Y, Watnick T, He N et al: Somatic PKD2 variants in individual kidney and liver cysts support a \"two-hit\" model of cystogenesis in type 2 autosomal dominant polycystic kidney disease. J Am Soc Nephrol 1999; 10: 1524\u20131529.","journal-title":"J Am Soc Nephrol"},{"key":"BFejhg201697_CR14","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/75981","volume":"25","author":"T Watnick","year":"2000","unstructured":"Watnick T, He N, Wang K et al: Variants of PKD1 in ADPKD2 cysts suggest a pathogenic effect of trans-heterozygous variants. Nat Genet 2000; 25: 143\u2013144.","journal-title":"Nat Genet"},{"key":"BFejhg201697_CR15","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1093\/hmg\/11.16.1845","volume":"11","author":"G Wu","year":"2002","unstructured":"Wu G, Tian X, Nishimura S et al: Trans-heterozygous Pkd1 and Pkd2 variants modify expression of polycystic kidney disease. Hum Mol Genet 2002; 11: 1845\u20131854.","journal-title":"Hum Mol Genet"},{"key":"BFejhg201697_CR16","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1177\/0300060513475956","volume":"41","author":"M Li","year":"2013","unstructured":"Li M, Qin S, Wang L, Zhou J : Genomic instability in patients with autosomal-dominant polycystic kidney disease. J Int Med Res 2013; 41: 169\u2013175.","journal-title":"J Int Med Res"},{"key":"BFejhg201697_CR17","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1097\/01.ASN.0000046963.60910.63","volume":"14","author":"J Gogusev","year":"2003","unstructured":"Gogusev J, Murakami I, Doussau M et al: Molecular cytogenetic aberrations in autosomal dominant polycystic kidney disease tissue. J Am Soc Nephrol 2003; 14: 359\u2013366.","journal-title":"J Am Soc Nephrol"},{"key":"BFejhg201697_CR18","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1136\/gutjnl-2014-308062","volume":"64","author":"MJ Janssen","year":"2014","unstructured":"Janssen MJ, Salomon J, Cnossen WR, Bergmann C, Pfundt R, Drenth JP : Somatic loss of polycystic disease genes contributes to the formation of isolated and polycystic liver cysts. Gut 2014; 64: 688\u2013690.","journal-title":"Gut"},{"key":"BFejhg201697_CR19","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.cell.2014.11.050","volume":"160","author":"M Huch","year":"2014","unstructured":"Huch M, Gehart H, van Boxtel R et al: Long-term culture of genome-stable bipotent stem cells from adult human liver. Cell 2014; 160: 299\u2013312.","journal-title":"Cell"},{"key":"BFejhg201697_CR20","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.jmoldx.2012.02.007","volume":"14","author":"YC Tan","year":"2012","unstructured":"Tan YC, Michaeel A, Blumenfeld J et al: A novel long-range PCR sequencing method for genetic analysis of the entire PKD1 gene. J Mol Diagn 2012; 14: 305\u2013313.","journal-title":"J Mol Diagn"},{"key":"BFejhg201697_CR21","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1086\/316904","volume":"67","author":"DM Reynolds","year":"2000","unstructured":"Reynolds DM, Falk CT, Li A et al: Identification of a locus for autosomal dominant polycystic liver disease, on chromosome 19p13.2-13.1. Am J Hum Genet 2000; 67: 1598\u20131604.","journal-title":"Am J Hum Genet"},{"key":"BFejhg201697_CR22","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1681\/ASN.2008050507","volume":"20","author":"Y Pei","year":"2009","unstructured":"Pei Y, Obaji J, Dupuis A et al: Unified criteria for ultrasonographic diagnosis of ADPKD. J Am Soc Nephrol 2009; 20: 205\u2013212.","journal-title":"J Am Soc Nephrol"},{"key":"BFejhg201697_CR23","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/j.ccr.2009.10.023","volume":"16","author":"DJ Baker","year":"2009","unstructured":"Baker DJ, Jin F, Jeganathan KB, van Deursen JM : Whole chromosome instability caused by Bub1 insufficiency drives tumorigenesis through tumor suppressor gene loss of heterozygosity. Cancer Cell 2009; 16: 475\u2013486.","journal-title":"Cancer Cell"},{"key":"BFejhg201697_CR24","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1056\/NEJMoa1104017","volume":"365","author":"MJ Lindhurst","year":"2011","unstructured":"Lindhurst MJ, Sapp JC, Teer JK et al: A mosaic activating variant in AKT1 associated with the Proteus syndrome. N Engl J Med 2011; 365: 611\u2013619.","journal-title":"N Engl J Med"},{"key":"BFejhg201697_CR25","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1126\/science.3175621","volume":"241","author":"JM Dunn","year":"1988","unstructured":"Dunn JM, Phillips RA, Becker AJ, Gallie BL : Identification of germline and somatic variants affecting the retinoblastoma gene. Science 1988; 241: 1797\u20131800.","journal-title":"Science"},{"key":"BFejhg201697_CR26","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1053\/j.gastro.2013.06.001","volume":"145","author":"RM de Voer","year":"2013","unstructured":"de Voer RM, Geurts van Kessel A, Weren RD et al: Germline variants in the spindle assembly checkpoint genes BUB1 and BUB3 are risk factors for colorectal cancer. Gastroenterology 2013; 145: 544\u2013547.","journal-title":"Gastroenterology"},{"key":"BFejhg201697_CR27","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1111\/j.1399-0004.2011.01637.x","volume":"81","author":"HE Yu","year":"2012","unstructured":"Yu HE, Hawash K, Picker J et al: A recurrent 1.71\u2009Mb genomic imbalance at 2q13 increases the risk of developmental delay and dysmorphism. Clin Genet 2012; 81: 257\u2013264.","journal-title":"Clin Genet"},{"key":"BFejhg201697_CR28","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1002\/hep.21952","volume":"47","author":"T Decaens","year":"2008","unstructured":"Decaens T, Godard C, de Reynies A et al: Stabilization of beta-catenin affects mouse embryonic liver growth and hepatoblast fate. Hepatology 2008; 47: 247\u2013258.","journal-title":"Hepatology"},{"key":"BFejhg201697_CR29","doi-asserted-by":"publisher","first-page":"5972","DOI":"10.1038\/sj.onc.1204825","volume":"20","author":"S Saadi-Kheddouci","year":"2001","unstructured":"Saadi-Kheddouci S, Berrebi D, Romagnolo B et al: Early development of polycystic kidney disease in transgenic mice expressing an activated mutant of the beta-catenin gene. Oncogene 2001; 20: 5972\u20135981.","journal-title":"Oncogene"},{"key":"BFejhg201697_CR30","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1002\/(SICI)1098-2264(199908)25:4<399::AID-GCC14>3.0.CO;2-X","volume":"25","author":"H Blaker","year":"1999","unstructured":"Blaker H, Hofmann WJ, Rieker RJ, Penzel R, Graf M, Otto HF : Beta-catenin accumulation and variant of the CTNNB1 gene in hepatoblastoma. Genes Chromosomes Cancer 1999; 25: 399\u2013402.","journal-title":"Genes Chromosomes Cancer"},{"key":"BFejhg201697_CR31","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1136\/gut.39.6.867","volume":"39","author":"FM Giardiello","year":"1996","unstructured":"Giardiello FM, Petersen GM, Brensinger JD et al: Hepatoblastoma and APC gene variant in familial adenomatous polyposis. Gut 1996; 39: 867\u2013869.","journal-title":"Gut"},{"key":"BFejhg201697_CR32","doi-asserted-by":"publisher","first-page":"3105","DOI":"10.1093\/hmg\/ddn208","volume":"17","author":"M Lal","year":"2008","unstructured":"Lal M, Song X, Pluznick JL et al: Polycystin-1 C-terminal tail associates with beta-catenin and inhibits canonical Wnt signaling. Hum Mol Genet 2008; 17: 3105\u20133117.","journal-title":"Hum Mol Genet"},{"key":"BFejhg201697_CR33","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.3748\/wjg.v18.i12.1328","volume":"18","author":"M Geng","year":"2012","unstructured":"Geng M, Cao YC, Chen YJ, Jiang H, Bi LQ, Liu XH : Loss of Wnt5a and Ror2 protein in hepatocellular carcinoma associated with poor prognosis. World J Gastroenterol 2012; 18: 1328\u20131338.","journal-title":"World J Gastroenterol"},{"key":"BFejhg201697_CR34","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/nrgastro.2012.254","volume":"10","author":"TJ Gevers","year":"2013","unstructured":"Gevers TJ, Drenth JP : Diagnosis and management of polycystic liver disease. Nat Rev Gastroenterol Hepatol 2013; 10: 101\u2013108.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"BFejhg201697_CR35","first-page":"1282","volume":"26","author":"R Sherstha","year":"1997","unstructured":"Sherstha R, McKinley C, Russ P et al: Postmenopausal estrogen therapy selectively stimulates hepatic enlargement in women with autosomal dominant polycystic kidney disease. Hepatology 1997; 26: 1282\u20131286.","journal-title":"Hepatology"},{"key":"BFejhg201697_CR36","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1053\/jarr.2003.50005","volume":"10","author":"AB Chapman","year":"2003","unstructured":"Chapman AB : Cystic disease in women: clinical characteristics and medical management. Adv Ren Replace Ther 2003; 10: 24\u201330.","journal-title":"Adv Ren Replace Ther"},{"key":"BFejhg201697_CR37","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/1750-1172-5-8","volume":"5","author":"NR Tartaglia","year":"2010","unstructured":"Tartaglia NR, Howell S, Sutherland A, Wilson R, Wilson L : A review of trisomy X (47,XXX). Orphanet J Rare Dis 2010; 5: 8.","journal-title":"Orphanet J Rare Dis"},{"key":"BFejhg201697_CR38","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1016\/S0140-6736(13)61407-5","volume":"382","author":"A Caroli","year":"2013","unstructured":"Caroli A, Perico N, Perna A et al: Effect of longacting somatostatin analogue on kidney and cyst growth in autosomal dominant polycystic kidney disease (ALADIN): a randomised, placebo-controlled, multicentre trial. Lancet 2013; 382: 1485\u20131495.","journal-title":"Lancet"},{"key":"BFejhg201697_CR39","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1681\/ASN.2009121291","volume":"21","author":"MC Hogan","year":"2010","unstructured":"Hogan MC, Masyuk TV, Page LJ et al: Randomized clinical trial of long-acting somatostatin for autosomal dominant polycystic kidney and liver disease. J Am Soc Nephrol 2010; 21: 1052\u20131061.","journal-title":"J Am Soc Nephrol"},{"key":"BFejhg201697_CR40","doi-asserted-by":"publisher","first-page":"783","DOI":"10.2215\/CJN.05380709","volume":"5","author":"A Caroli","year":"2010","unstructured":"Caroli A, Antiga L, Cafaro M et al: Reducing polycystic liver volume in ADPKD: effects of somatostatin analogue octreotide. Clin J Am Soc Nephrol 2010; 5: 783\u2013789.","journal-title":"Clin J Am Soc Nephrol"},{"key":"BFejhg201697_CR41","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1097\/MOG.0b013e328343433f","volume":"27","author":"TJ Gevers","year":"2011","unstructured":"Gevers TJ, Drenth JP : Somatostatin analogues for treatment of polycystic liver disease. Curr Opinion Gastroenterol 2011; 27: 294\u2013300.","journal-title":"Curr Opinion Gastroenterol"},{"key":"BFejhg201697_CR42","doi-asserted-by":"publisher","first-page":"7283","DOI":"10.1038\/sj.onc.1210547","volume":"26","author":"LB Hesson","year":"2007","unstructured":"Hesson LB, Cooper WN, Latif F : Evaluation of the 3p21.3 tumour-suppressor gene cluster. Oncogene 2007; 26: 7283\u20137301.","journal-title":"Oncogene"},{"key":"BFejhg201697_CR43","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1158\/0008-5472.92.65.1","volume":"65","author":"S Tommasi","year":"2005","unstructured":"Tommasi S, Dammann R, Zhang Z et al: Tumor susceptibility of Rassf1a knockout mice. Cancer Res 2005; 65: 92\u201398.","journal-title":"Cancer Res"},{"key":"BFejhg201697_CR44","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1002\/ijc.20944","volume":"115","author":"I Tischoff","year":"2005","unstructured":"Tischoff I, Markwarth A, Witzigmann H et al: Allele loss and epigenetic inactivation of 3p21.3 in malignant liver tumors. Int J Cancer 2005; 115: 684\u2013689.","journal-title":"Int J Cancer"},{"key":"BFejhg201697_CR45","doi-asserted-by":"publisher","first-page":"1538","DOI":"10.1128\/MCB.26.4.1538-1548.2006","volume":"26","author":"C Thivierge","year":"2006","unstructured":"Thivierge C, Kurbegovic A, Couillard M, Guillaume R, Cote O, Trudel M : Overexpression of PKD1 causes polycystic kidney disease. Mol Cell Biol 2006; 26: 1538\u20131548.","journal-title":"Mol Cell Biol"}],"container-title":["European Journal of Human Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/ejhg201697.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ejhg201697","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ejhg201697.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T17:17:58Z","timestamp":1684430278000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ejhg201697"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,24]]},"references-count":45,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["BFejhg201697"],"URL":"https:\/\/doi.org\/10.1038\/ejhg.2016.97","relation":{},"ISSN":["1018-4813","1476-5438"],"issn-type":[{"value":"1018-4813","type":"print"},{"value":"1476-5438","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8,24]]},"assertion":[{"value":"3 January 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2016","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 June 2016","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2016","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}